Table 2 Cardiovascular mortality in HD patients categorized by cigarette smoking status and occurrence of NIDDM nephropathy.
Cause of death | Log-rank test P-value | HR (95% CI) | Wald test on 1 df, P-value | Adjusted P-valuea |
|---|---|---|---|---|
HD cigarette smokers and HD non-smokers as a reference group | ||||
Cardiovascular | 0.4 | 0.899 (0.699–1.156) | 0.69, 0.4 | 0.699 |
All cardiac | 0.2 | 0.836 (0.629–1.110) | 1.53, 0.2 | 0.437 |
Cardiac related with CHD | 0.4 | 0.842 (0.585–1.212) | 0.86, 0.4 | 0.490 |
Cardiac non-related with CHD | 0.4 | 0.819 (0.516–1.301) | 0.71, 0.4 | 0.730 |
NIDDM nephropathy patients and non-diabetics as a reference group | ||||
Cardiovascular | 0.01 | 1.348 (1.071–1.696) | 6.47, 0.01 | 0.026 |
All cardiac | 0.09 | 1.256 (0.961–1.640) | 2.78, 0.1 | 0.143 |
Cardiac related with CHD | 0.005 | 1.648 (1.154–2.354) | 7.56, 0.006 | 0.016 |
Cardiac non-related with CHD | 0.7 | 0.920 (0.602–1.405) | 0.15, 0.7 | 0.765 |
NIDDM nephropathy smokers and non-diabetic smokers as a reference group | ||||
Cardiovascular | 0.3 | 1.306 (0.820–2.079) | 1.26, 0.3 | 0.432 |
All cardiac | 0.5 | 1.186 (0.706–1.992) | 0.41, 0.5 | 0.753 |
Cardiac related with CHD | 0.05 | 1.938 (0.986–3.809) | 3.69, 0.05 | 0.235 |
Cardiac non-related with CHD | 0.6 | 0.813 (0.347–1.909) | 0.23, 0.6 | 0.853 |
NIDDM nephropathy non-smokers and non-diabetic non-smokers as a reference group | ||||
Cardiovascular | 0.02 | 1.360 (1.041–1.778) | 5.08, 0.02 | 0.029 |
All cardiac | 0.1 | 1.288 (0.940–1.765) | 2.47, 0.1 | 0.116 |
Cardiac related with CHD | 0.05 | 1.516 (0.989–2.323) | 3.65, 0.06 | 0.050 |
Cardiac non-related with CHD | 0.9 | 1.04 (0.638–1.695) | 0.02, 0.9 | 0.898 |
